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Abstract. 
 
The signal recognition particle and its recep-
tor (SR) target nascent secretory proteins to the ER. 
SR is a heterodimeric ER membrane protein whose 
subunits, SR
 
a
 
 and SR
 
b
 
, are both members of the GTP-
ase superfamily. Here we characterize a 27-kD protein 
in 
 
Saccharomyces cerevisiae
 
 (encoded by 
 
SRP102
 
) as a 
homologue of mammalian SR
 
b
 
. This notion is sup-
ported (
 
a
 
) by Srp102p’s sequence similarity to SR
 
b
 
; (
 
b)
 
 
by its disposition as an ER membrane protein; (
 
c
 
) by its 
interaction with Srp101p, the yeast SR
 
a
 
 homologue; 
and (
 
d)
 
 by its role in SRP-dependent protein targeting 
in vivo. The GTP-binding site in Srp102p is surprisingly 
insensitive to single amino acid substitutions that inacti-
vate other GTPases. Multiple mutations in the GTP-
binding site, however, inactivate Srp102p. Loss of activ-
ity parallels a loss of affinity between Srp102p and 
Srp101p, indicating that the interaction between SR 
subunits is important for function. Deleting the trans-
membrane domain of Srp102p, the only known mem-
brane anchor in SR, renders SR soluble in the cytosol, 
which unexpectedly does not significantly impair SR 
function. This result suggests that SR functions as a reg-
ulatory switch that needs to associate with the ER 
membrane only transiently through interactions with 
other components.
Key words: protein targeting • signal recognition par-
ticle • 
 
Saccharomyces cerevisiae • 
 
endoplasmic reticu-
lum • GTPase
 
L
 
ocalization
 
 of proteins to their correct subcellular
compartments is required for eukaryotic cells to
maintain the high degree of order required for life.
In mammalian cells, protein translocation across the ER
membrane is thought to occur primarily in a cotransla-
tional manner. Secretory protein synthesis initiates on cy-
toplasmic ribosomes, and is completed only after those ri-
bosomes have been targeted to the ER (for reviews see
Rapoport et al., 1996; Walter and Johnson, 1994). The sig-
nal recognition particle (SRP)
 
1
 
 initially selects cytosolic ri-
bosomes for targeting to the ER if they are synthesizing
nascent polypeptides containing NH
 
2
 
-terminal hydropho-
bic signal sequences. Signal sequences, as they emerge
from the ribosome, bind tightly to SRP, causing a transient
pause in the translation of the nascent secretory protein.
Targeting of this complex to the ER occurs via an interac-
tion between SRP and the SRP receptor (SR), a hetero-
dimeric protein anchored in the ER membrane (Gilmore
et al., 1982
 
a
 
; Gilmore et al., 1982
 
b
 
; Meyer et al., 1982).
This interaction results in localization of the nascent pro-
tein to the ER, releases the SRP-induced translational ar-
rest, and allows the nascent chain/ribosome complex to
dissociate from SRP/SR. Concomitantly, the ribosome/na-
scent chain is handed over to the translocon, comprised
principally of the Sec61 protein complex (Görlich and
Rapoport, 1993; Hanein et al., 1996) that effects transloca-
tion of the nascent chain across the lipid bilayer. The
translocon forms a protein pore through which the nascent
polypeptide crosses the hydrophobic environment of the
lipid bilayer (Hanein et al., 1996). Thus, SRP and SR are
required for initial targeting of the ribosome/nascent chain
to the ER to form the ribosome/translocon junction. The
two components therefore couple cytoplasmic translation
to the translocation of proteins across the lipid bilayer of
the ER membrane.
SRP and SR have been identified in all living cells exam-
ined, including eukaryotic cells, bacteria, and archaea
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(Bult et al., 1996, Walter and Johnson, 1994), indicating
that SRP-dependent protein targeting is universally con-
served. Identification of homologues of SRP and SR sub-
units in yeast has allowed study of the role of these compo-
nents in vivo using primarily reverse genetic approaches
(Brown et al., 1995). Studies in yeast have also revealed
that in addition to the SRP-dependent cotranslational
pathway, an SRP-independent pathway exists that oper-
ates in parallel and mediates posttranslational transloca-
tion (Hann and Walter, 1991). The signal sequence of the
nascent polypeptide determines which route the substrate
will take to the ER membrane (Ng et al., 1996). 
In eukaryotes, both SRP and SR are multisubunit com-
plexes. SRP is a ribonucleoprotein that consists of six dis-
tinct protein subunits and SRP RNA (7SL RNA; Walter
and Blobel, 1980; Walter and Blobel, 1982); SR is a het-
erodimeric ER membrane protein consisting of a 69-kD
peripheral membrane protein (SR
 
a
 
) and a 30-kD integral
membrane protein (SR
 
b
 
; Tajima et al., 1986). The best-
characterized and phylogenetically most conserved SRP
subunit, SRP54, contains the signal sequence–binding ac-
tivity of SRP, interacts with the SRP RNA, and mediates
binding of SRP to SR (Krieg et al., 1986; Kurzchalia et al.,
1986, Römisch et al., 1989; Siegel and Walter, 1988; Zopf
et al., 1990). In addition, SRP54 contains a GTPase do-
main (Bernstein et al., 1989; Römisch et al., 1989). Both
subunits of SR also contain GTPase domains, and GTP
binding to all three GTPases—SRP54, SR
 
a
 
, and SR
 
b
 
—
has been experimentally demonstrated (Connolly and
Gilmore, 1986; Connolly and Gilmore, 1989; Miller et al.,
1995). Thus, three distinct directly interacting GTPases
collaborate in protein targeting, and the elucidation of the
mechanisms with which their respective GTPase cycles
control the targeting events is of considerable interest.
The GTPase domains of SRP54 and SR
 
a
 
 are related,
defining their own subfamily in the GTPase superfamily as
recently underscored by the elucidation of the crystal
structure of their prokaryotic homologues (Freymann et al.,
1997; Montoya et al., 1997). According to a current model
for the cycle of GTP binding and hydrolysis of SRP54 and
SR
 
a
 
, as SRP54 binds to the signal sequence of a nascent
secretory protein, it becomes stabilized in a state display-
ing a low affinity for GTP (Miller et al., 1993; Rapiejko
and Gilmore, 1997). Interaction with the ribosome may
enhance SRP54’s affinity for GTP (Bacher et al., 1996).
Targeting of this complex to the ER membrane and inter-
action of SRP with SR effects a further increase in the af-
finity of SRP54 for GTP. The resulting change in confor-
mation of SRP54 is thought to accompany release of the
signal sequence from SRP, leaving the ribosome/nascent
chain complex free to interact with components of the
translocon. SRP then remains associated with SR after re-
lease of the ribosome/nascent chain complex until hydrol-
ysis of the GTPs bound to SRP54 and SR
 
a
 
 results in dis-
sociation of SRP from SR. Hydrolysis occurs by an
enzymatically reciprocal interaction, as SRP54 and SR
 
a
 
act as GTPase-activating proteins for each other while
they are in the GTP-bound state (Powers and Walter,
1995), possibly reflecting the structural relatedness of the
two interacting GTPase domains.
The role of the GTPase domain in SR
 
b
 
 has remained
more enigmatic. The GTPase domain of SR
 
b
 
 is structur-
 
ally distinct from those of SR
 
a
 
 and SRP54; it falls into its
own subfamily of GTPases with its closest, albeit still rela-
tively distant relative being Sar1p, an ARF-like GTPase
involved in ER-to-Golgi trafficking (Miller et al., 1995).
We describe here the first functional characterization of
yeast SR
 
b
 
 (Srp102p) encoded by the 
 
SRP102
 
 gene. We
show that Srp102p anchors Srp101p (the yeast SR
 
a
 
 homo-
logue) to the ER membrane, consistent with its disposition
as an integral ER membrane protein. Unexpectedly, how-
ever, a mutant form of Srp102p lacking the trans-
membrane domain is functional in yeast, indicating that
Srp102p is not required solely to tether Srp101p to the
membrane. In contrast, mutations that sufficiently disrupt
the GTP-binding site of Srp102p inactivate SR. Most
of these mutants also disrupt the interaction between
Srp101p and Srp102p, suggesting that an interaction of
Srp102p with Srp101p may be required to activate Srp101p
as a prerequisite for a productive interaction with SRP
during protein targeting.
 
Materials and Methods
 
Strains, Antibodies, Materials, and General Methods
 
Yeast strains are listed in Table I. Genetic techniques are performed as
described previously, except where noted (Sherman and Lawrence, 1974).
Yeast transformation was performed by the lithium acetate procedure
(Ito et al., 1983). Yeast DNA for Southern analysis was prepared as de-
scribed (Davis et al., 1980). Recombinant DNA techniques and Southern
blots were performed as described (Sambrook et al., 1989). Western blots
were visualized using enhanced chemiluminescence (Amersham Corp.,
Arlington Heights, IL) as described by the manufacturer. Oligonucle-
otides were synthesized on a Cyclone Plus™ DNA synthesizer (Millipore,
Novato, CA) and purified according to the manufacturer’s instructions.
Both high and low-copy yeast shuttle vectors used are as described (Chris-
tianson et al., 1992, Sikorski and Heiter, 1989) unless otherwise indicated.
Chemicals are from Sigma Chemical Co. (St. Louis, MO) unless otherwise
noted. The plasmid library used for cloning 
 
SRP102
 
 was obtained from
the American Type Culture Collection (catalog no. 37415; Rockville,
MD). Anti-Kar2p serum was prepared in our laboratory using Kar2p
overexpressed in 
 
Escherichia coli
 
 from a clone kindly provided by Joe Vo-
gel and Mark Rose (Rose et al., 1989). 0.5 
 
m
 
l of anti-Kar2p serum was
used per OD
 
600
 
 in nonnative immunoprecipitations. Fluorochrome-cou-
pled anti-rabbit IgG and anti-mouse IgG secondary antibodies are from
Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA). Anti-
Srp101p is used as described in Ogg et al. (1992). Monoclonal 12CA5
(anti-HA) and 9E10 (anti-myc) were purchased from Berkeley Antibody
Company (Richmond, CA), and were used at a dilution of 1:10,000 on
Western blots.
 
 
 
DNA sequencing was performed using an ABS A220 fluo-
rescent DNA sequencer (Perkin-Elmer Corp., Norwalk, CT) and cycle se-
quencing.
 
Cloning of SRP102
 
Initial attempts to clone 
 
SRP102
 
 using PCR from genomic DNA, and the
known sequence to design oligonucleotides resulted in the clones having
multiple sequence errors, presumably from inaccurate PCR. Therefore, a
genomic clone of 
 
SRP102
 
 was isolated by screening a plasmid library pre-
pared from 
 
Saccharomyces cerevisiae
 
 strain GRF88 in the vector YCp50
using one of the PCR-obtained clones as a probe to screen the library
(Rose et al., 1987). One of the plasmids obtained in the initial PCR at-
tempt to clone 
 
SRP102
 
 was random-primed using the Ready To Go™
DNA labeling kit according to the manufacturer’s instructions (Pharmacia
Biotech, Inc., Piscataway, NJ). Three plasmids were isolated from the li-
brary screen (designated pSO451a, b, and c) that contained identical in-
serts, and the 2966-bp EcoRI fragment predicted to contain 
 
SRP102
 
 was
subcloned into the EcoRI sites of pRS314, pRS316, and pRS426 yielding
plasmids pSO454, pSO452, and pSO453, respectively. Both strands of the
insert in pSO452 were sequenced from nucleotides 175– 821, and this se-
quence agreed with the published genomic sequence. Confirmation that 
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these plasmids contained a functional open reading frame was obtained by
complementation of the 
 
SRP102
 
 gene disruption.
 
Gene Disruption
 
We generated a null allele of 
 
SRP102
 
 in a two-step fashion. First we used
PCR to generate DNA fragments corresponding to the 5
 
9
 
 and 3
 
9
 
 flanking
regions of 
 
SRP102, 
 
and subcloned these into pBluescript II SK (
 
1
 
) (Strat-
agene, La Jolla, CA), engineering a SmaI site at the junction between the
flanking sequences. The 
 
HIS3
 
 gene was then inserted into the SmaI site,
generating pSO446, now carrying the 
 
HIS3
 
 gene between the 5
 
9
 
 and 3
 
9
 
flanking regions of 
 
SRP102
 
. A linear fragment carrying the 
 
SRP102
 
 dis-
ruption allele was generated and used to transform the diploid yeast strain
W303, giving rise to strain SOY133. Transformants were induced to
sporulate. Genomic DNA prepared from the heterozygous diploid
(SOY133), wild-type parent (W303), and representative spores from a sin-
gle tetrad were used as template in PCR. When DNA from the wild-type
parent and the His
 
2
 
 spores was used as template in the PCR, the expected
 
z
 
1.42-kb fragment was seen. Use of the DNA isolated from the His
 
1
 
spores gave rise to a single expected 
 
z
 
2.65-kb fragment. Only when DNA
prepared from the heterozygous diploid was used as template in the reac-
tion were both the 1.42-kb and the 2.65-kb fragments seen.
 
Plasmid and Strain Construction
 
To construct a plasmid containing 
 
SRP102
 
 under control of the 
 
GAL1
 
/
 
10
 
promoter, we used PCR to produce a fragment corresponding to the
 
SRP102
 
 coding sequences, and subcloned this fragment into pTS210 (plas-
mid kindly provided by Tim Stearns, Stanford University, Palo Alto, CA),
generating pSO460. This plasmid was transformed into SOY133, and the
resulting Ura
 
1
 
 prototrophs were induced to sporulate. Asci were dis-
sected, and spores were allowed to germinate at room temperature on
YEP plates containing 2% galactose and 2% sucrose as carbon sources.
Colonies that were both Ura
 
1
 
 and His
 
1
 
 were chosen for further study.
The fact that His
 
1
 
, Ura
 
1
 
 colonies arose that grew with wild-type rates sup-
ports our assignment of the initiation codon, as Srp102p expressed from
pSO460 starts at this codon. Additionally, these His
 
1
 
, Ura
 
1
 
 colonies were
incapable of growing for more than a few generations on plates containing
2% glucose as the sole carbon source, indicating that we had indeed
placed 
 
SRP102
 
 under conditional control.
To generate the strains we used in our fractionation and immunofluores-
cence studies, we placed plasmids containing Srp102p (pSO454, no epitope
tag), or Srp102p-HA (pSO459), or Srp102p-myc (pSO457) into SOY133
(W303 background) or SOY329 (TR1 background), and induced the dip-
loid transformants to sporulate. Spores giving rise to colonies that were
both His
 
1
 
 (
 
SRP102
 
::
 
HIS3
 
) and Trp
 
1
 
 (containing a plasmid) and that grew
at wild-type rates were chosen for further study, and these strains were des-
ignated as indicated in Table I. We constructed pSO457 in the following
manner: a PCR product containing the SRP102-coding sequence was li-
gated into pCS118 (plasmid kindly provided by Caroline Shamu, Harvard
University, Boston, MA). pCS118 contains a 400-bp insert harboring the
myc tag, stop codons in all three reading frames, and an actin transcriptional
terminator in YEplac112 (Geitz and Sugino, 1988). Thus, pSO457 contains
the 
 
SRP102
 
 coding sequence fused at the COOH terminus to the myc tag
followed by an actin terminator, all in the YEplac112 (TRP1, 2
 
m
 
) backbone.
A similar strategy was used to construct pSO459 using pSF19 (plasmid
kindly provided by Peter Sorger, Massachusetts Institute of Technology,
Boston, MA) as the recipient vector. This plasmid contains SRP102-HA in
the pRS314 backbone (TRP1, CEN/ARS).
To construct the 
 
D
 
TMD strain, 66 bp of 
 
SRP102
 
 (coding for amino ac-
ids 3–24 of Srp102p) were deleted from pSO454 by recombinant PCR
(Higuchi et al., 1988) using Vent polymerase (New England Biolabs, Bev-
erly, MA). Both strands of the truncated 
 
SRP102
 
 gene of this plasmid
were sequenced to show that only the desired deletion had been intro-
 
Table I. Yeast Strains and Plasmids Used in This Study
 
Strain Genotype Reference
 
W303
 
ade2-1/ade2-1 trp1-1/trp1-1 leu2-3, 112/leu2-3, 112 his3-11/his3-11 ura3-1/ura3-1
 
Deshaies and Schekman, 1990
 
can1-100/can1-100
 
 MAT
 
a
 
/MAT
 
a
 
TR1
 
trp1/trp1 lys2/lys2 his3/his3 ura3/ura3 ade2/ade2
 
 MAT
 
a
 
/MAT
 
a
 
Parker et al., 1988
TR2
 
trp1 lys2 his3 ura3 ade2
 
 MAT
 
a
 
Parker et al., 1988
TR3
 
trp1 lys2 his3 ura3 ade2
 
 MAT
 
a
 
Parker et al., 1988
SOY133 W303 MAT
 
a
 
/MAT
 
a
 
 
 
SRP102/srp102
 
::
 
HIS3
 
This study
SOY162 W303 MAT
 
a
 
 
 
srp102
 
::
 
HIS3
 
This study
SOY195 W303 MAT
 
a
 
 
 
srp101
 
::
 
ADE2, srp102
 
::
 
HIS3
 
This study
SOY246 SOY162 [pSO462] This study
SOY223 SOY162 [pSO459] This study
SOY201 SOY162 [pSO454] This study
SOY264 SOY162 [pSO462] [pSO211] This study
SOY268 SOY162 [pSO462] [pSO400] This study
SOY329 TR1 
 
SRP102/srp102
 
::
 
HIS3
 
This study
SOY335 TR3 
 
srp102
 
::
 
HIS3
 
 [pSO459] This study
WBY338 WBY618 [pWB209] This study
WBY618 TR2 
 
srp102
 
::
 
HIS3
 
This study
WBY632 TR3 
 
srp102
 
::
 
HIS3
 
 [pSO452] This study
WBY752 TR3 
 
srp101
 
::
 
ADE2 srp102
 
::
 
HIS3
 
 [pSO431] [pWB209] This study
WBY823 TR2 
 
srp101
 
::
 
ADE2 srp102::HIS3 [pWB209] This study
Plasmids Markers Backbone Reference
pSO452 URA3, SRP102, CEN6/ARSH4 pRS316 Sikorski and Heiter, 1989
pSO454 TRP1, SRP102, CEN6/ARSH4 pRS314 Sikorski and Heiter, 1989
pSO457 TRP1, SRP102-myc, REP3 YEplac112 Geitz and Sugino, 1988
pSO431 URA3, SRP101-HA, CEN6/ARSH4 pRS316 Sikorski and Heiter, 1989
pSO459 TRP1, SRP102-HA, CEN6/ARSH4 pRS314 Sikorski and Heiter, 1989
pSO462 TRP1, srp102(K51I)-HA, CEN6/ARSH4 pRS314 Sikorski and Heiter, 1989
pSO211 URA3, SRP101, CEN6/ARSH4 pRS316 Sikorski and Heiter, 1989
pSO400 URA3, pGAL-SRP101, CEN6/ARSH4 pRS316 Sikorski and Heiter, 1989
pWB670 TRP1, srp102-DTMD-HA, CEN6/ARSH4 pRS314 Sikorski and Heiter, 1989
pWB209 TRP1, srp102-DTMD, CEN6/ARSH4 pRS314 Sikorski and Heiter, 1989The Journal of Cell Biology, Volume 142, 1998 344
duced. The diploid heterozygous strain SOY329 was transformed to Trp1
prototrophy with pWB209, and a transformant was induced to undergo
meiosis. Tetrads were dissected and allowed to germinate on minimal
plates lacking tryptophan. All His1 spores (containing the srp102::HIS3
deletion allele) that were also Trp1 (containing pWB209, the DTMD al-
lele) gave rise to colonies of similar size as the His2 colonies (containing
the wild-type SRP102 allele).
To replace the transmembrane domain (TMD) of Srp102p with an HA
epitope tag, recombinant PCR was used in the same manner as described
for the construction of pWB209. The resulting plasmid, pWB670, encodes
a mutated Srp102p protein with an NH2-terminal HA tag instead of the
TMD domain. We replaced pSO452 in strain WBY632 with pWB670 us-
ing the plasmid-shuffle technique, generating strain WBY670.
Preparation of Antibodies Specific to Srp102p
Antiserum was raised against a fusion protein expressed in E. coli, con-
taining glutathione-S-transferase from S. japonicum as the NH2-terminal
domain linked to the soluble domain of Srp102p. To generate this fusion
protein, a DNA fragment coding all but the NH2-terminal 24 amino acids
of Srp102p was amplified by PCR using Vent polymerase (New England
Biolabs, Beverly, MA), generating the fusion protein plasmid, pSO488.
The GST-Srp102p fusion protein, containing amino acids 25–244 of
Srp102p, was soluble when it was overexpressed in E. coli at 248C. Cells
were lysed by sonication, and the fusion protein was purified using glu-
tathione-agarose (Sigma Chemical Co.) as described (Smith and Johnson,
1988). Polyclonal rabbit antiserum against the fusion protein was prepared
by Berkeley Antibody Company (Richmond, CA). Antisera were used
without further purification.
Site-directed Mutagenesis
Site-directed mutagenesis was performed by the method of Kunkel
(Kunkel, 1985; Kunkel et al., 1987). Single-stranded uracil-rich DNA used
for template was prepared from the phagemid pSO459 (containing
SRP102-HA). Plasmids that were recovered from a mutagenesis reaction,
and that were subsequently confirmed to have incorporated the desired
mutation, are designated with the wild-type amino acid in single letter
code, position of the amino acid changed, and the name of the new amino
acid in single letter code (e.g., S49A signifies that a serine at position 49
has been changed to an alanine). Every mutation was confirmed by se-
quencing the recovered plasmid. The following is a compilation of each of
the mutations obtained, and the corresponding oligonucleotide that was
used to produce that mutation (wild-type sequences are in normal type
and the codon changed is in bold; nucleotide(s) that are noncomplemen-
tary to the rescued strand of pSO459 are shown underlined): pSRP102-
S49A (oSRP102-25) 59-CGT TTT TCC AGC ATT TTG AGG-39;
pSRP102-K51I (oSRP102-16) 59-G CAA GCT CGT AAT TCC AGA
ATT TTG-39; pSRP102-T52N (oSRP102-17) 59-CGT AAG CAA GCT
ATT TTT TCC AGA-39; pSRP102-T66A (oSRP102-22) 59-GA AAC
AAC AGC TGG TCT TAC-39; pSRP102-G90L (oSRP102-18) 59-CTT
GAC ATG CAA TGG GAA GTC-39; pSRP102-H91L (oSRP102-20) 59-
CAA CTT GAC CAA GCC TGG GAA GT-39; pSRP102-N154I
(oSRP102-19) 59-C GCT TTT AAT GCA TGC AAT TAA G-39;
pSRP102-E157Q (oSRP102-15) 59-GT GAA CAA TTG GCT TTT ATT
GC-39; pSRP102-S220A (oSRP102-23) 59-GC AAC TAC AGC TGC
TTC C-39; pSRP102-K51A, T52A (oSRP102-21) 59-CGT AAG CAA
GCT AGC AGC TCC AGA ATT TTG-39; pSRP102-N154A, E157A
(oSRP102-24) 59-GC AGT GAA CAA AGC GCT TTT AGC GCA TGC
AAT TAA G-39; pSRP102-DS49 (oSRP102-26) 59-CT CGT TTT TCC
AGC AGC AGC ACC TGC AAT G-39; pSRP102-K51I, H91L
(oSRP102-16 1  oSRP102-20) see above; pSRP102-K51I, N154I
(oSRP102-16  1  oSRP102-19) see above; pSRP102-K51A,T52A, H91L
(oSRP102-21 1 oSRP102-20) see above; pSRP102-K51A, T52A, E157Q
(oSRP102-21  1  oSRP102-15) see above; pSRP102-H91L, N154I
(oSRP102-20  1 oSRP102-19) see above; pSRP102-H91L, N154A/E157A
(oSRP102-20  1 oSRP102-24) see above; pSRP102-H91L, E157Q
(oSRP102-20  1 oSRP102-15) see above.
Cell Fractionation
Cell fractionation by differential centrifugation was performed as de-
scribed in Ogg et al. (1992) with the following modifications. Zymolyase-
100T (ICN Biomedicals, Costa Mesa, CA) instead of lyticase was used at 5
mg/OD600 to convert cells into spheroplasts. Only PMSF and leupeptin
were included as protease inhibitors. Whole-cell lysate cleared of unbro-
ken cells and nuclei (low-speed supernatant, see below) was used as the
starting material for separation of the ER membrane from cytosol using
isopycnic centrifugation. 2.5 OD600 cell equivalents of the low-speed su-
pernatant (50 ml of 50 OD600/ml) was diluted with 200 ml 2.5 M sucrose in
flotation buffer (FB; 10 mM Hepes-KOH, pH 7.5, 150 mM KOAc, pH 7.5,
5 mM Mg(OAc)2, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, 0.5 mg/ml leu-
peptin) to 10 OD600/ml. This dilution served to raise the density of the
low-speed supernatant so that it could be placed underneath a discontinu-
ous sucrose gradient. Gradients were formed in TLS-55 polycarbonate
tubes (Beckman, Palo Alto, CA). Each gradient consisted of the following
from top to bottom: 0.6 ml of 0.8 M sucrose in FB; 1.6 ml of 1.8 M sucrose
in FB; 0.2 ml of the load described above, equal to 2.0 OD600 U. Gradients
were centrifuged at 55,000 rpm in the TLS-55 rotor in a TL100 tabletop ul-
tracentrifuge for 4 h. Each gradient was fractionated into 10 240-ml frac-
tions, and proteins in each fraction was precipitated with ice-cold TCA
added to a final concentration of 10% before analysis by Western blot.
Immunofluorescence
Immunofluorescence was performed essentially as described (Pringle et al.,
1989). Anti-HA, and anti-myc antibodies were used at dilutions of 1:200
to 1:2,000. Anti-Kar2p antibodies were used at a dilution of 1:10,000.
Bound primary antibodies were decorated with either FITC-conjugated
donkey anti–mouse IgG or TRITC-conjugated donkey anti–rabbit IgG
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) diluted
1:50. Slides were mounted in 90% glycerol containing 1 mg/ml p-phe-
nylenediamine, pH 9.0, and containing 1 mg/ml 49, 6-diamino-2-phenylin-
dole (DAPI).
Immunoprecipitations
Denaturing immunoprecipitations were performed as described (Ogg et al.,
1992). Nondenaturing immunoprecipitations were performed from deter-
gent-solubilized membranes in the following manner: cells were grown to
0.5 OD600/ml in synthetic complete medium lacking amino acids used for
maintenaning a plasmid containing SRP102-HA. Typically, 30 total OD600
were harvested at a time. After pelleting in a clinical centrifuge and wash-
ing with 50 mM NaCl, 20 mM NaN3, cells were resuspended in buffer A
(Tris-SO4, pH 9.4, 10 mM DTT) at 10 OD600/ml, and were incubated at
room temperature for 20 min. Conversion of the cells to spheroplasts was
then achieved by harvesting the cells in a clinical centrifuge and resus-
pending them in spheroplast media (50 mM Tris-Cl, pH 7.5, 1.2 M Sorbi-
tol, 5 mM MgCl2, 5 mM DTT, 10 mM NaN3) at 20 OD600/ml. We used 5
mg/OD600 Zymolyase 100-T (ICN Biomedicals, Costa Mesa, CA) to digest
the cell walls during a 30-min incubation at 308C. Efficiency of spheroplas-
ting was monitored by phase contrast microscopy. Spheroplasts were re-
covered by centrifugation through a cushion (twice the volume of the
spheroplasting cells) of spheroplast media containing 1.9 M sorbitol but
no DTT at 7,800 g for 5 min (7,000 rpm in a Beckman JS-13 rotor). All
subsequent steps were performed at 48C. Spheroplasts were resuspended
in lysis buffer (LB; 200 mM Sorbitol, 25 mM NaPi, pH 7.5, 150 mM NaCl,
5 mM MgCl2, 1 mM PMSF, 0.5 mg/ml of leupeptin, 1 mM EDTA) at 100
OD600/ml. Cells were lysed by adding 3/4 vol of Zirconium beads (BioSpec
Products, Bartlesville, OK) and vortexing gently (setting 3 on a scale of
1–10) for four rounds of lysis. Each round consisted of 15 s of vortexing
followed by a 15-s cooling period in an ice-water bath. Lysate was re-
moved from the beads, which were washed once with ice-cold LB. The ly-
sate and bead wash were combined, and the unbroken cells and nuclei
were removed by centrifugation at 370 g (1,200 rpm in a JS-13) for 4 min.
This step was critical; longer centrifugation resulted in loss of most of the
ER as judged by the pelleting of an ER marker, Srp101p. The low-speed
supernatant containing crude membranes was transferred to TLA100.1
polycarbonate tubes, and membranes were pelleted by centrifugation at
43,630 g for 12 min (35,000 rpm in the Beckman TLA100.1 rotor in a
Beckman TL100 tabletop ultracentrifuge). The membrane pellet was
washed (30 OD600/ml) with LB. This wash was achieved by first resus-
pending the pellet in a minimal volume of LB (20–40 ml), followed by dilu-
tion to the appropriate volume with LB. Again, the membranes were pel-
leted by centrifugation in the TL100 as above. The final membrane pellet
was resuspended in LB 1 10% glycerol (GLB) to 50 OD600/ml using the
same technique as described above to ensure even membrane resuspen-
sion. Membranes were solubilized by adding 1/10th vol of 10% Triton
X-100 (Calbiochem, La Jolla, CA) and incubation at 48C for 20 min. After
incubation, the detergent-solubilized membranes were cleared by centrif-
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TLA100.1) for 25 min. The resulting lysate was frozen in liquid nitrogen
and stored at 2808C.
Immunoprecipitations were performed by diluting 2 OD600 U (40 ml) of
the above lysate into 560 ml of GLBT (GLB containing 1% Triton X-100).
Nonspecific binding of proteins in the lysate to Sepharose was removed by
adding 30 ml of a 50% slurry of Sepharose CL-4B (Pharmacia Biotech
Sverige, Uppsala, Sweden) and rotating for 30 min at 48C. Sepharose
beads were removed by centrifuging in an Eppendorf microfuge and
transferring the lysate to a new tube. Antibody–sepharose bead com-
plexes (10 ml; corresponding to 3 ml of the 12CA5 ascites fluid) were
added, and the tube was mixed by rotating at 48C for 15 min. We found
that with the 12CA5 antibody, longer incubation times of the antibody–
bead complex resulted in lower recovery of Srp101p in the immunoprecip-
itation. The 12CA5 antibody used in the native immunoprecipitations was
covalently attached to a Sepharose matrix by using the Affinica antibody
coupling kit (Schleicher & Schuell, Inc., Keene, NH) and the manufac-
turer’s instructions. After extensive washing, the antibody bead complex
was stored as a 50% slurry in PBS containing 10 mM NaN3.
Results
Disruption and Cloning of SRP102
Database searches revealed an open reading frame
(YKL154w) encoding a putative GTPase of unknown
function on S. cerevisiae chromosome XI that has signifi-
cant structural similarity to mammalian SRb (Miller et al.,
1995). Data presented below confirm that this gene indeed
encodes the yeast homolog of mammalian SRb and plays
an essential role in the SRP-dependent protein-targeting
pathway to the ER membrane. Henceforth, we refer to
this gene encoding the b-subunit of the SRP receptor as
SRP102, consistent with the designation of the gene en-
coding the a-subunit of the SRP receptor as SRP101 (Ogg
et al., 1992). By convention, we shall refer to the corre-
sponding gene products as Srp102p and Srp101p, respec-
tively.
As the first step towards a molecular genetic character-
ization of SRP102, we examined the phenotype of a gene
deletion. To this end we replaced the central portion of
one copy of SRP102 in diploid cells with the selectable
marker  HIS3 (see Methods). Tetrad analysis after sporula-
tion of this strain resulted in four viable spores, two of
which grew at wild-type rates while the other two grew
with a much reduced rate (Fig. 1, SRP102 vs. srp102::
HIS3). In each of seven tetrads analyzed, the growth de-
fect, the His1 phenotype, and the srp102::HIS3 gene dis-
ruption (as monitored by PCR analysis; see Methods) al-
ways segregated 2:2 from the SRP102 wild-type allele.
Thus, we conclude that the loss of SRP102 was directly re-
sponsible for the growth defect.
We isolated a plasmid carrying the functional SRP102
gene from a yeast genomic DNA library (see Materials
and Methods). An EcoRI fragment containing the entire
open reading frame and flanking sequences was sub-
cloned, generating plasmid pSO452 (URA3). To show that
the information contained in this sequence was sufficient
to complement the srp102::HIS3 gene disruption, plasmid
pSO452 was transformed into diploid SRP102/srp102::
HIS3  cells. After sporulation, asci were dissected, and the
colonies resulting from germination of each of the four
spores were analyzed. In all tetrads analyzed (12), each
spore that contained the srp102::HIS3 gene disruption (as
detected by the His1 phenotype) and that grew at wild-
type rates also contained plasmid pSO452 (as detected by
the Ura1 phenotype). This result confirms that pSO452 is
required for srp102::HIS3 cells to grow at wild-type rates,
and thus contains all the information necessary for func-
tional expression of the SRP102. 
The slow growth phenotype of cells bearing the srp102::
HIS3 gene disruption closely resembles that of cells in
which SRP101 or any of the seven known genes encoding
SRP subunits are disrupted. Furthermore, srp102::HIS3
mutant cells—like yeast cells depleted of other SRP com-
ponents—are rho2, and thus require a fermentable carbon
source. Finally, yeast cells in which both SRP101 and
SRP102 (Fig. 1) or SRP54 and SRP102 (not shown) are
disrupted have a growth defect indistinguishable from
cells bearing any single gene disruption, consistent with
the notion that these genes operate in the same pathway.
Taken together, with the significant sequence similarities
between Srp102p and mammalian SRb, these results
strongly suggest that Srp102p is an essential component of
the SRP-dependent targeting pathway in S. cerevisiae.
Srp102p is Important for Translocation of Proteins into 
the ER
To show directly that Srp102p plays a role in the SRP-
dependent protein translocation pathway, we asked if pro-
tein translocation defects could be detected upon Srp102p
inactivation. To this end, we used a temperature-sensitive
allele of SRP102, srp102(K51I), that was isolated by site-
directed mutagenesis (see below). Haploid cells containing
the chromosomal srp102::HIS3 gene disruption and bearing
a plasmid that encodes the srp102(K51I) mutant allele were
shifted from the permissive (248C) to the restrictive temper-
ature (378C). The growth curve indicates that within 2 h
after the temperature shift, the strain carrying the
srp102(K51I) allele decreases its growth rate by about six-
fold (Fig. 2 A). This difference in doubling time (2 vs. 12 h,
respectively) resembles the difference between the wild-
type and the isogenic srp102::HIS3 deletion strain (Fig. 1),
indicating that Srp102p is inactivated upon temperature
shift (note that the growth differences in Fig. 1 are less pro-
nounced, however, because cells were grown in rich media.)
Figure 1. Cell growth rates of srp102 mutant strains. Growth rates
in YEPD medium at 308C were determined for wild-type (SRP102,
WBY618 bearing pSO452) cells, cells in which the chromosomal
SRP102 gene is deleted alone (srp102::HIS3, WBY618) or in combi-
nation with the SRP101 gene (srp101::ADE2, srp102::HIS3,
SOY195), or in which the chromosomal deletion is covered by srp102-
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To monitor the effect of Srp102p inactivation on protein
translocation, we pulse-labeled srp102(K51I) cells with
[35S]methionine at different time points after shifting to
the restrictive temperature. Lysates from labeled cells
were analyzed by immunoprecipitation with antibodies
raised against proteins that are known to be translocated
across the ER membrane. Using antibodies specific for
Kar2p, an ER lumenal protein, accumulation of the un-
translocated precursor form preKar2p was detected (Fig. 2
B, lanes 7–10). The slower mobility of preKar2p in SDS-
PAGE results from the presence of its signal sequence,
which is normally cleaved upon entry into the ER. Signifi-
cant amounts of pre-Kar2p are apparent at the earliest
time point taken after placing the cells at the restrictive
temperature (2-h time point in Fig. 2 B, lane 7). In similar
experiments, we have detected a comparable fraction of
preKar2p as early as 30 min after the temperature shift. As
expected, no preKar2p was detected in the control strain
carrying the wild-type allele of SRP102 (Fig. 2 B, lanes
1–5). Note that at later time points after the temperature
shift, the translocation defect of Kar2p is diminished (Fig.
2 B, lanes 8–10). This adaptation of cells in response to the
loss of the SRP-dependent targeting pathway was previ-
ously observed after shut-off of the synthesis of SRP com-
ponents and Srp101p (Ogg et al., 1992). Adaptation is a
physiological change in the cells that either improves the
efficiency of the alternative targeting pathway or helps de-
grade cytosolic precursor molecules more efficiently.
The severity of translocation defects varies widely for
different proteins in the strains from which Srp101p or
SRP components are depleted (Hann and Walter, 1991;
Ogg et al., 1992).  We obtained similar results when radio-
labeled extracts of temperature-shifted cells bearing the
srp102(K51I) allele were analyzed for translocation de-
fects of two additional proteins, dipeptidyl aminopepti-
dase B (DPAP-B), a vacuolar membrane protein, and car-
boxypeptidase Y (CPY), a soluble vacuolar protein (not
shown). The membrane integration of DPAP-B, like
Kar2p, was significantly affected as Srp102p was rendered
nonfunctional upon temperature shift, whereas the trans-
location of CPY was completely unaffected. These results
closely mimic those obtained upon inactivation of other
gene products that function in the SRP-dependent protein
targeting pathway and lend further support to the notion
that Srp102p functions as an essential subunit of the SRP
receptor in the same pathway.
We monitored the fate of mutant Srp102p by Western
blotting to determine if the loss of Srp102p activity is due
to the degradation of the protein at the restrictive temper-
ature. To this end, we took advantage of an HA-epitope
tag (see below) that was added to the COOH-terminal end
of Srp102p during construction of the mutant allele. West-
ern blot analysis of lysates made from wild-type control
and srp102(K51I) cells during a time course after the
temperature shift shows that the steady-state level of
Srp102(K51I)p does not change significantly during the
duration of the 10 h time course (Fig. 2 C, lanes 6–10).
This  result suggests that the temperature sensitivity of
srp102(K51I) is not due to destabilization and subsequent
degradation of Srp102(K51I)p at the restrictive temperature.
As an alternative means to deplete cells of Srp102p, we
placed SRP102 under the control of the GAL1/GAL10
promoter to regulate its expression. Srp102p was depleted
by switching cells from galactose-(where SRP102 is ex-
pressed) to glucose- (where SRP102 is repressed) contain-
ing media. We monitored growth and protein transloca-
tion as described above. As Srp102p was depleted, cells
showed a fivefold decrease in their growth rate, and pre-
cursors of Kar2p and DPAP-B, but not CPY, accumulated
to similar degrees as described above and shown previ-
ously in analogous experiments (Hann and Walter, 1991,
Ogg et al., 1992, Brown et al., 1994) for the depletion of
the other known components that function in the SRP-
dependent protein targeting pathway (not shown).
Figure 2. Srp102p is important for protein translocation. (A)
Growth curves. Growth of a wild-type strain (SOY162, srp102::
HIS3 covered by pSO459; open squares) compared with a strain
containing the srp102(K51I) ts allele of SRP102 (SOY162,
srp102::HIS3 covered by pSO462; closed circles). At time zero
(arrow) a culture in midlogarithmic growth of each of the strains
growing in synthetic media lacking histidine and tryptophan (to
select both for the deletion and the plasmid expressing either the
wild-type Srp102p or Srp102[K51I]p) was shifted from 248C to
378C. Cell growth was monitored by change in the OD600 of the
culture. (B) Kar2p immunoprecipitation. Cells grown as in A
were labeled with [35S]methionine for 7 min, and were harvested
at the times indicated after a shift from 248C to 378C and pro-
cessed for immunoprecipitation. Lysates at each of the time
points indicated were immunoprecipitated with anti-Kar2p and
subjected to SDS-PAGE followed by fluorography. Position of
both mature and precursor forms of Kar2p are indicated. (C)
Western blot. 0.5 OD600 cell equivalents of the lysate prepared in
B were subjected to SDS-PAGE and subsequent transfer to ni-
trocellulose. Srp102p-HA or Srp102(K51I)p-HA was detected
with the anti-HA monoclonal antibody, and was visualized by en-
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Srp102p is Localized to the ER
To characterize the cellular disposition of Srp102p, we
constructed two alleles in which the wildtype SRP102 gene
is appended with sequences encoding epitopes that can be
recognized by well-characterized monoclonal antibodies
recognizing either a 12–amino acid sequence derived from
influenza virus hemagglutinin (HA epitope; Field et al.,
1988) or an 11–amino acid sequence derived from the
mammalian c-myc protein (myc epitope; Evan et al.,
1985). Both epitope-tagged versions—Srp102p-HA and
Srp102p-myc—are fully functional (as judged by their abil-
ity to complement the growth defect of cells in which
SRP102 is disrupted), and are specifically recognized by
the cognate antibodies on Western blots (not shown).
Based on its structural and functional homology to
mammalian SRb, Srp102p should be an integral mem-
brane protein of the yeast ER. To test this prediction,
we fractionated lysates prepared from cells expressing
Srp102p-HA by differential centrifugation. After low-
speed centrifugation, Srp102p-HA present in the total ex-
tract (Fig. 3, lane 1) partitioned about equally between the
pellet (Fig. 3, lane 3) and the supernatant fractions (Fig. 3,
lane 2). Presence of Srp102p in the low-speed pellet is pre-
sumably due to incomplete cell lysis. Further fractionation
of the low-speed supernatant at 100,000 g resulted in com-
plete sedimentation of Srp102p (Fig. 3, lanes 4 and 5), sug-
gesting that Srp102p is associated with a particulate mem-
brane fraction.
The association of Srp102p with this fraction was further
characterized by treatment of the low-speed supernatant
with reagents known to perturb protein–protein or pro-
tein–lipid interactions before centrifugation at 100,000 g.
Treatment with 600 mM potassium acetate (Fig. 3, lanes 6
and 7), 1.6 M urea (Fig. 3, lanes 8 and 9), or sodium car-
bonate at pH 11.5 (Fig. 3, lanes 12 and 13) did not solubi-
lize Srp102p, which, under all conditions was recovered in
the membrane fraction. In contrast, treating the low-speed
supernatant with 0.5% Triton X-100 resulted in solubiliza-
tion of roughly 50% of Srp102-HA, which was recovered
in the high-speed supernatant fraction (Fig. 3, compare
lanes  10 and 11).
As controls for these experiments, we also probed the
Western blot with antibodies to Sec61p, a bona fide yeast
ER integral membrane protein (Deshaies and Schekman,
1987), and Srp101p, which is a peripheral ER membrane
protein (Ogg et al., 1992). Srp102p-HA cofractionated un-
der all conditions with Sec61p. In particular, both Srp102p
and Sec61p were recovered in the pellet fraction after al-
kali treatment, whereas Srp101p was completely extracted
and recovered in the supernatant fraction (Fig. 3, compare
lanes 12 and 13). Thus, we conclude that Srp102p-HA, and
by extension Srp102p, is an integral membrane protein.
This conclusion is consistent with the predictions from its
amino acid sequence that shows a stretch of 19 hydropho-
bic amino acids forming a putative transmembrane do-
main near its amino terminus.
To further support our conclusion that Srp102p is a
membrane protein of the yeast ER, we visualized the dis-
tribution of the epitope-tagged form of the protein by indi-
rect immunofluorescence microscopy. Cells expressing the
myc-tagged version of Srp102p from a 2m plasmid are
shown in Fig. 4. After formaldehyde fixation, cells were in-
cubated with the appropriate primary and FITC, or
TRITC-conjugated secondary antibodies (Fig. 4, B, E, and
H); nuclei and mitochondria were visualized with the
DNA-binding dye DAPI (Fig. 4, C, F, and I). Anti-myc
antibodies detected the characteristic yeast ER-staining
pattern (Fig. 4 E) consisting of a distinct perinuclear ring
with fine strands of staining passing through the cytoplasm
connecting the perinuclear ER to ER cisternae underlying
the plasma membrane. Staining was variable; some cells in
every field stained very brightly, while others stained less
brightly or not at all. We attribute this staining to variation
in the copy number of the 2m plasmid in the population.
Expression of Srp102p-HA from a CEN/ARS plasmid re-
sulted in a less intense but qualitatively identical pattern
(not shown). This pattern closely resembled that obtained
in control samples stained with anti-Kar2p antibodies (Fig.
4  H). Wild-type cells (expressing Srp102p without an
epitope tag) showed only background staining (Fig. 4 B).
Taken together, the results from the fractionation experi-
ments and the results from the immunofluorescence mi-
croscopy support our conjecture that Srp102p is an inte-
gral ER membrane protein.
Srp101p and Srp102p Form a Stable Complex
in the ER
Mammalian SRa and SRb are subunits of a heterodimeric
complex (Tajima et al., 1986). To test whether the yeast
homologues Srp101p and Srp102p are likewise associated,
we asked if we could coimmunoprecipitate Srp101p with
Srp102p. We immunoprecipitated Srp102p-HA with anti-HA
Figure 3. Subcellular localization of Srp102p. Extracts from
cells (srp102::HIS3 bearing pSO459) were fractionated as de-
tailed in Materials and Methods. Equivalent amounts (0.5 OD600)
of each fraction were analyzed by Western blot using anti-HA
monoclonal antibodies, affinity-purified anti-Srp101p antibodies,
or anti-Sec61p antibodies. Lane 1, total cell lysate(T); lane 2, low-
speed supernatant (LS); lane 3, low-speed pellet (LP); lanes 6–13
contain the supernatant (lanes 6, 8, 10, and 12 [S]) or the pellet
(lanes 7, 9, 11, and 13 [P]) after a portion of the low-speed super-
natant was diluted with lysis buffer (lanes 4 and 5 [HS and HP])
or adjusted to a final concentrations of 600 mM potassium acetate
(lanes 6 and 7 [KOAc]), 1.6 M urea (lanes 8 and 9 [Urea]), 0.5%
Triton X-100 (lanes 10 and 11 [TX-100]), or 0.1 M Na2CO3 (lanes
12 and 13, [pH 11.5]) and centrifuged at 100,000 g. Only the rele-
vant portion of each blot is shown. For comparison, the same
fractions were also blotted with anti-Srp101p, a peripheral mem-
brane protein, and anti-Sec61p, a previously characterized inte-
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antibodies from extracts prepared by detergent solubili-
zation of yeast microsomal membranes under nondena-
turing conditions. Immune complexes were subsequently
solubilized in SDS sample buffer and subjected to SDS-
PAGE followed by Western blot analysis. The blots were
probed with affinity-purified polyclonal antibody directed
against Srp101p. The results show that Srp101p was recov-
ered in the eluate fraction from the HA-agarose beads
when cells expressed Srp102p-HA (Fig. 5 A, lane 4), but
was found exclusively in the supernatant fraction when
cells expressed untagged Srp102p (Fig. 5 A, lanes 1 and 2)
or when a peptide containing the HA epitope was added to
compete for binding of the anti-HA antibody to Srp102p-
HA (Fig. 5 A, lanes 5 and 6). These biochemical data
strongly suggest that Srp101p and Srp102p directly interact
to form a complex.
In vivo evidence for an interaction between Srp101p
and Srp102p was obtained by genetic means. To this
end, we used cells expressing the temperature-sensitive
srp102(K51I) allele. As temperature-sensitive mutations
can often be suppressed by overproducing interacting pro-
teins, we asked whether overexpression of Srp101p could
suppress the growth defect induced at the restrictive tem-
perature. We transformed cells expressing Srp102(K51I)p
either with a plasmid bearing SRP101 under control of the
GAL1/10 promoter, or with a plasmid bearing SRP101 un-
der the control of its own promoter. Each of these strains
grew at wild-type rates at the permissive temperature us-
ing either dextrose or galactose as the carbon source (not
shown). As expected, at the restrictive temperature nei-
ther plasmid suppressed the growth defect when cells were
grown on glucose-containing media (Fig. 5 B, glucose
plate). In contrast, the plasmid bearing the galactose-
inducible SRP101, but not the control SRP101 plasmid,
suppressed the growth defect when cells were grown on ga-
lactose-containing media (Fig. 5 B, galactose plate). Under
the galactose-induced conditions, Srp101p was z50-fold
overexpressed as estimated by Western blot (Ogg et al.,
1992). Significantly, galactose-inducible SRP101 failed to
suppress the growth defect of cells containing a complete
deletion of SRP102 rather than the srp(K51I) allele, even
when these cells were grown in galactose (not shown).
Srp102p Anchors Srp101p to the ER Membrane
Biochemical studies that monitor extraction behavior of
the SR subunits (both those shown in Fig. 3 and those per-
formed in the mammalian system) suggested that SRa is a
peripheral, whereas SRb, which contains a TMD, is an in-
tegral membrane protein (Miller et al., 1995). This sug-
gested a hierarchy of interactions with the membrane in
which SRa binds to SRb, which in turn is anchored in the
membrane via its TMD. To test this notion in vivo, we
asked whether Srp101p would be localized to the mem-
brane even in the absence of Srp102p.
To this end, we prepared a crude cell extract as for the
experiments described in Fig. 3, containing cellular mem-
branes (including ER) as well as cytosol. To assess mem-
brane association, we raised the density of the extract by
adding sucrose, and placed this solution underneath a su-
crose step gradient of lesser density (see Materials and
Methods). Centrifugation of the gradient to equilibrium
causes membranes to float to regions in the gradient that
are equal to their buoyant density. In contrast to the dif-
ferential velocity centrifugation used in Fig. 3, this method
allows us to distinguish conclusively the membrane associ-
ation of components (in which case they will float to re-
gions of lighter density) from aggregation (in which case
Figure 4. Immunofluorescent localization
of Srp102p to the ER. SOY162 cells con-
taining either pSO454 (Srp102p lacking an
epitope tag, A–C and G–I) or pSO457
(Srp102p-myc,  D–F) were fixed with
formaldehyde and probed with anti-myc
(A–F) or anti-Kar2p (G–I) followed by
secondary decoration with FITC-conju-
gated donkey anti-mouse IgG (A–F) or
TRITC-conjugated donkey anti–rabbit
IgG (G–I). The image in B is exposed for
twice the length of time as the image
shown in E. Phase contrast images are
shown in A, D, and G; fluorescein fluores-
cence is shown in B and E; rhodamine flu-
orescence is shown in H, and DAPI stain-
ing of the nuclei and mitochondria is
shown in C, F, and I. 
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they will remain in the denser sucrose fractions or sedi-
ment into a pellet). After centrifugation, phosphoglucoki-
nase (PGK), a cytosolic enzyme marker, consistently re-
mained in fractions 9 and 10 at the bottom of the gradient
(Fig. 6 
 
F
 
), while most of Sec61p, an integral ER membrane
protein, moved to fractions 2–4 (Fig. 6 
 
G
 
), thereby identi-
fying these fractions as those that contain the ER.
As expected, the majority of Srp101p was found associ-
ated with membranes (Fig. 6 
 
A
 
, compare fractions 2–4
with fractions 9 and 10) when we monitored the fraction-
ation behavior of the protein in extracts prepared from
wild-type cells (
 
SRP102
 
). This ratio is reversed in 
 
srp102
 
::
 
HIS3
 
 cells (Fig. 6 
 
B
 
). Thus, deletion of Srp102p resulted in
the release of the majority of Srp101p into the cytosol. A
significant fraction of Srp101p, however, still cofraction-
ated with membranes from cells in which Srp102p was de-
leted. In contrast, the vast majority of Srp102p was always
found in the membrane fractions, irrespective of whether
 
SRP101
 
 was deleted or not (data not shown). From these
data we conclude that Srp102p contributes significantly to
the localization of SR to the ER membrane. A minor frac-
tion of Srp101p, however, still interacts (directly or indi-
Figure 5. Srp101p and Srp102p interact. (A) Detergent-solubilized
microsomes were prepared from cells (lanes 1 and 2, SOY162
bearing pSO454, no tag; lanes 3–6, Srp102p-HA, SOY162 bearing
pSO459) as described in Materials and Methods. Solubilized
microsomes were subjected to immunoprecipitation using anti-HA
either in the absence (lanes 1–4) or the presence (lanes 5 and 6) of
excess HA peptide (NH2-YPYDVPDYA-COOH). Immunopre-
cipitated proteins were eluted from HA-agarose beads, subjected
to SDS-PAGE, and analyzed by Western blot using affinity-puri-
fied anti-Srp101p antibodies. Eluates from each of the immuno-
precipitations are shown in lanes 2, 4, and 6 (E); supernatants
shown in lanes 1, 3, and 5 (S). Lane 7 contains 2 OD600 cell equiv-
alents of solubilized membranes as a marker for the amount of
Srp101p that is in each of the immunoprecipitations (T). (B)
SOY162 cells bearing the srp102(K51I) allele on plasmid pSO462
were transformed with either pSO400 (SRP101 under galactose
regulation) or pSO211 (SRP101 under control of its own pro-
moter) and plated onto synthetic plates lacking tryptophan and
uracil, and containing 2% galactose or 2% glucose as the sole car-
bon source. (Glucose), plate containing 2% glucose incubated at
378C for 3 d. (Galactose) plate containing 2% galactose incubated
at 378C for 3 d.
Figure 6. Fractionation behavior of Srp101p and Srp102 during
perturbation of the SR. Whole-cell lysate from cells was layered
under a 2.4-ml discontinuous sucrose gradient, and was centri-
fuged to equilibrium. Equivalent amounts of the load fraction
(lane L) and fractions from the gradient (lanes 1–10) were ana-
lyzed by Western blot using anti-Srp101p, anti-Srp102p, anti-
PGK, or anti-Sec61p antisera. Fractionation behavior of Srp101p
was compared between strains containing either wild-type
Srp102p ([A] SRP102, WBY618 bearing pSO452) or the srp102::
HIS3 deletion ([B], WBY618). As controls, fractionation of the
cytosolic enzyme phosphoglucokinase ([F] PGK) or the integral
ER membrane protein Sec61p (G) was also monitored in a strain
wild-type for SRP102 (WBY618 bearing pSO452) to identify
those fractions containing cytosol or membranes. Srp102p frac-
tionation was also monitored in wild-type cells ([C] SRP102,
WBY618 bearing pSO452) as was fractionation of Srp102p-
DTMD in cells either containing or lacking Srp101p ([D]
WBY618 bearing pWB209; [E] WBY823). Direction of sedimen-
tation is indicated by an arrow, and the fractions containing cyto-
sol (lanes 9 and 10) or membranes (lanes 2–4) are also indicated
above.
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rectly) with membranes, even in the absence of its partner
Srp102p. As srp102 mutant cells are phenotypically identi-
cal to mutant cells lacking other SRP pathway components
(see above); however, the small amount of Srp101p that is
membrane-associated in a srp102::HIS3 cell is not func-
tional, or is insufficient to provide significant SR activity.
Mutations in the GTP-binding Site Result in 
Compromised SR Complex Formation
Much of the cytosolic portion of Srp102p constitutes its
GTPase domain. We therefore considered the possibility
that the GTPase domain of Srp102p might play a role in
anchoring Srp101p. We made site-directed mutations in the
predicted GTP-binding site of Srp102p, in particular in the
consensus motifs (G-boxes) that by analogy to other GTP-
ases are predicted to constitute loops on the surface of the
domain that directly contribute to the nucleotide-binding
pocket (Bourne et al., 1991). Many mutations in these con-
served elements of other GTPases have been made and
functionally characterized. In many cases, corresponding
mutations in related GTPases have similar consequences
on the enzymatic properties of the enzymes, allowing the
molecular phenotypes to be predicted. Based on the infor-
mation available for other GTPases, we made site-directed
point mutations in Srp102p based on their predicted effect
(listed in Table II together with predicted molecular phe-
notypes, if known). In addition to nine single amino acid
changes, we made several mutations that either changed
multiple amino acids in a single G-box, or changed amino
acids in multiple G-boxes at the same time (Table II).
Plasmids encoding the mutant forms of SRP102 were
transformed into diploid SRP102/srp102::HIS3 cells, which
were then sporulated, and haploid cells bearing both the
chromosomal srp102::HIS3 deletion and the plasmid were
selected. Using this approach rather than transforming a
haploid SRP102–deleted strain directly, we avoided poten-
tial complication arising from cells having grown in the ab-
sence of the SRP-dependent targeting pathway, such as
their turning rho2. Table II lists the growth phenotype of
each mutation. Surprisingly, in eight of the twelve cases
where mutations are confined to a single G-box, cells car-
rying the mutant allele grew with wild-type rates. The
other four mutants (K51I, T52N, G90L, and N154I) re-
sulted in cells that were temperature-sensitive for growth
and for protein translocation (the results for K51I were
discussed above in Fig. 2, A and B). In contrast, in each of
the seven cases where an allele consisted of mutations in
more than one of the G-boxes, we observed either a tem-
perature-sensitive or null phenotype (Table II), indicating
that mutations in more than one of the G-boxes are far
more detrimental than the same mutations in either one of
the boxes. For example, combination of the K51A/T52A
allele with the H91L allele resulted in a null phenotype,
whereas no growth phenotype was observed for either of
those mutations by themselves.
Western blots revealed that even when combinatorial
mutants result in a null phenotype, the mutant forms of
Srp102p were still present in cells at wild-type levels. Fig. 2
C, for example, shows that srp102(K51I) does not cause
Srp102p to be degraded at the nonpermissive temperature.
Similar results were obtained for the other mutant alleles
(Table II). Thus, the mutant phenotypes are not due to
degradation of the mutant forms of Srp102p.
Table II. Site-directed Mutations in the GTP Binding Site of Srp102p
Allele G-box location Expression Phenotype Effect of mutation Reference
Single amino acid changes in a single G-box
S49A G-1 Yes wild type reduced GTP hydrolysis Barbacid, 1987
K51I G-1 Yes ts reduced nucleotide affinity Pai et al., 1990
T52N G-1 Yes ts increased affinity for GEF,
reduced affinity for GTP Peyroche et al., 1996
T66A G-2 Yes wild type prevents GTP-dependent
interaction with GAP Sigal et al., 1986
G90L G-3 Yes ts unknown
H91L G-3 Yes wild type reduced GTPase activity Jonak et al., 1994
N154I G-4 Yes ts impaired nucleotide exchange Sigal et al., 1986
E157Q G-4 Yes wild type reduced affinity for GTP Weijland et al., 1994
S220A G-5 ND wild type bypass requirement for GEF Camonis and Jacquet, 1988
Multiple amino acid changes in a single G-box
P46A,Q47A,N48A,DS49 G-1 Yes wild type unknown
K51A,T52A G-1 Yes wild type unknown
N154A,E157A G-4 Yes wild type unknown
Multiple amino acid changes in multiple G-boxes
H91L,N154I G-3, G-4 Yes ts unknown
H91L,N154A,E157A G-3, G-4 ND ts unknown
H91L,E157Q G-3, G-4 Yes ts unknown
K51I,H91L G-1, G-3 Yes null unknown
K51I,N154I G-1, G-4 ND null unknown
K51A,T52A,H91L G-1, G-3 Yes null unknown
K51A,T52A,E157Q G-1, G-4 ND null unknown
Each site-directed mutation is listed along with its location in G-boxes 1–5 (nomenclature according to Bourne et al., 1991) and the observed growth phenotype when the mutant
allele is present as the only copy of Srp102p is a haploid cell. Except for the mutants indicated by ND, wild-type expression levels of mutant proteins were confirmed by Western
blot analysis. Most mutations were chosen on the basis of their predicted molecular phenotypes inferred from characterized defects in other GTPases as indicated. 
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To gain further insight into the biochemical defect caus-
ing the temperature sensitivity of 
 
srp102(K51I)
 
 cells, we
fractionated extracts prepared from cells expressing an
HA-tagged version of the mutant protein (Srp102p[K51I]
p-HA) by differential centrifugation. Fig. 7 shows the re-
sults of such an experiment in which cells had been grown
at the permissive temperature 24
 
8
 
C. As expected and reca-
pitulating the results shown in Fig. 3, Srp101p and Srp102p
cofractionate in 
 
SRP102
 
 wild-type cells (Fig. 7 
 
A
 
). In
 
srp102(K51I)
 
 cells the fractionation of Srp102p is un-
changed, but strikingly, the fractionation of Srp101p is
grossly altered (Fig. 7 
 
B
 
). In particular, about half of the
Srp101p that is present in the low-speed supernatant frac-
tion (lane 
 
2
 
) is now recovered as an apparently soluble
protein in a high-speed supernatant (lane 
 
4
 
). Moreover,
the remaining portion that partitioned into the high-speed
pellet fraction was not extracted by detergent (1% Triton
X-100), but instead was recovered as an apparent aggre-
gate in the pellet fraction (lane 
 
7
 
). From these studies we
conclude that the interaction between Srp101p and Srp102p
is severely altered in 
 
srp102(K51I)
 
 mutant cells, even at
permissive conditions, and that increased temperature ex-
acerbates this defect, leading to the temperature-sensitive
phenotype. In support of this hypothesis is the fact that
overexpression of Srp101p in 
 
srp102(K51I)
 
 mutant cells
rescues the growth defect seen at the nonpermissive tem-
perature in these cells (Fig. 5 
 
B
 
).
We also tested four additional temperature-sensitive
mutant strains for suppression by the Srp101p-overex-
pressing plasmid pSO400. The growth defects at the non-
permissive temperature of three of these strains, bearing
 
srp102(G90L)
 
, 
 
srp102(N154I)
 
, and 
 
srp102(H91L, E157Q)
 
,
respectively, were all suppressed upon overproduction of
Srp101p (T. Hu and P. Walter, unpublished observation).
This result suggests that the observed effect is not allele-
specific, but that, as for 
 
srp102(K51I)
 
 cells, the affinity of
Srp102p and Srp101p may be weakened by the mutations.
In contrast, 
 
srp102(T52N)
 
 cells remained temperature-
sensitive, even when Srp101p was overexpressed; this mu-
tation therefore defines a phenotypically distinct class of
mutants.
 
Deletion of the Transmembrane Domain of SRP102 
Does Not Perturb its Function
 
The results presented so far suggested that the GTPase
domain of Srp102p may be involved in recruiting Srp101p
to the ER membrane and, in this role, may be essential for
SRP receptor function. We decided to test this notion by
perturbing the membrane association of the SRP receptor
by a different strategy. To this end, we constructed an al-
lele of 
 
SRP102
 
 in which the 19–amino acid TMD was de-
leted. We expected that 
 
srp102-
 
D
 
TMD
 
 cells would exhibit
the phenotype characteristic of cells lacking the SRP-
dependent protein targeting pathway, because neither
Srp101p nor Srp102p would be localized correctly to the
ER membrane. To our surprise, we found that the 
 
srp102-
 
D
 
TMD
 
 mutant allele efficiently complemented the growth
defect of 
 
srp102
 
::
 
HIS3 
 
disruption cells. As shown in Fig. 1,
the growth rate of cells expressing Srp102p-
 
D
 
TMD resem-
bles the growth rate of cells expressing wild-type Srp102p,
and is clearly distinct from the growth rate seen in cells
containing the 
 
SRP102
 
 disruption.
These results suggested that Srp102p-
 
D
 
TMD may be ca-
pable of performing its function in SRP-dependent protein
targeting with close to wild-type efficiency. To test this no-
tion further, we asked whether the Srp102p-
 
D
 
TMD allele
compromised protein translocation in vivo. We pulse-
labeled Srp102p-
 
D
 
TMD cells with [
 
35
 
S]methionine, and
immunoprecipitated proteins known to be translocated
into the ER as described for Fig. 2. Neither substrates that
are SRP-dependent (e.g., DPAP-B) nor substrates that are
SRP-independent (e.g. CPY) showed detectable translo-
cation defects (not shown). Thus, we conclude that the
TMD of Srp102p is not required for SR to perform its
function.
To test whether removal of the TMD releases Srp102p
from the ER membrane, we determined the intracellular
distribution of Srp102p-
 
D
 
TMD by subcellular fraction-
ation and indirect immunofluorescence. To this end, we
subjected a lysate derived from cells expressing Srp102p-
 
D
 
TMD to isopycnic centrifugation in a sucrose step gradi-
ent. As shown in Fig. 6, the majority of Srp102p-
 
D
 
TMD
indeed remains at the bottom of the gradient in contrast
to Srp102p found in wild-type cells (compare Fig. 6 
 
D
 
,
fractions 9 and 10, with Fig. 6 
 
C
 
, fractions 9 and 10),
Figure 7. SR subunits dissociate in cells bearing srp102(K51I)p.
Cells bearing wild-type Srp102p-HA (SOY162 containing pSO459)
or Srp102(K51I)p-HA (SOY162 containing pSO462) were sub-
jected to fractionation as detailed in Materials and Methods.
Equivalent amounts of each fraction were subjected to SDS-
PAGE, followed by Western blot analysis. Srp101p was detected
with affinity-purified anti-Srp101p antibodies, while Srp102p was
detected using the anti-HA monoclonal antibody. Each panel con-
tains the fractions loaded in the same manner. Lane 1: (T) total
cell lysate; lane 2: (LS), low-speed supernatant; lane 3 (LP), low-
speed pellet; lane 4, (HS), high-speed supernatant; lane 5, (HP),
high-speed pellet; lane 6, (DE), detergent extract; lane 7, (DP),
detergent pellet. (A) fractions from Srp102p-HA cells grown at
248C. (B) fractions from Srp102(K51I)p-HA grown at 248C.The Journal of Cell Biology, Volume 142, 1998 352
whereas most of the ER membrane in the mutant cells
floated to fractions 3 and 4 as indicated by fractionation of
the Sec61p integral membrane marker protein (not shown).
The primarily cytoplasmic localization of Srp102-DTMD was
confirmed by indirect immunofluorescence (not shown). A
small portion (z25%) of Srp102p-DTMD did, however, co-
fractionate with ER membrane (Fig. 6 D, lane 3).
Because Srp101p may contain additional residues that
contribute to association of the SR with the ER membrane
(Hortsch et al., 1985; Lauffer et al., 1985), we next asked
whether we could achieve a complete release of Srp102p-
DTMD into cytosolic fractions in a cell in which both
Srp101p and the TMD of Srp102p were deleted. As shown
in Fig. 6 E, the fractionation behavior of Srp102p-DTMD
is identical whether or not Srp101p is present in the cells.
From these data, we conclude that Srp102p is likely to in-
teract with ER membranes through interactions in addi-
tion to those afforded by its TMD or its partner subunit
Srp101p.
Because deletion of the TMD of Srp102p showed little
effect on cell growth or on protein translocation, and be-
cause the data presented above suggest that the majority
of Srp102p-DTMD has been released from the ER mem-
brane, we asked whether Srp101p and Srp102p-DTMD
still form a heterodimer in the cytosol. To this end, we pre-
pared a cytosol fraction from Srp102p-DTMD cells (also
bearing an HA-tagged allele of SRP101) and performed a
coimmunoprecipitation experiment similar to that shown
in Fig. 5. Coimmunoprecipitated proteins were separated
by SDS-PAGE; Srp101p, and Srp102p-DTMD were de-
tected by Western blotting using polyclonal rabbit antisera
(Fig. 8). A significant portion of Srp102p-DTMD in the ex-
tract (Fig. 8 A, lane 1, T) was recovered in the eluate frac-
tion from the HA-agarose beads when cells expressed the
HA-tagged version of Srp101p (Fig. 8 A, lane 3, E), but
was found exclusively in the supernatant fraction when
cells contain untagged Srp101p (Fig. 8 A, lane 5, S), indi-
cating that Srp102p-DTMD is associated with Srp101p-HA
in the extract. This result was confirmed by the con-
verse  experiment: anti-Srp102p serum immunoprecipi-
tated Srp101p-HA (Fig. 8 B, lane 3), followed by detection
of Srp101p-HA with the monoclonal antibody directed
against the HA tag.
Discussion
Our results demonstrate that Srp102p is the yeast homo-
logue of SRb. This notion is strongly supported by several
independent lines of evidence: (a) by Srp102p’s strong se-
quence and structural similarity to the mammalian SRb;
(b) by its disposition as an integral, ER-localized mem-
brane protein; (c) by the growth and protein translocation
defects exhibited in srp102 mutant cells, and (d) by its
physical association and genetic interaction with Srp101p.
Like mammalian SRb, Srp102p is a GTPase that is an-
chored by an amino-terminal TMD in the ER membrane.
The identification of the yeast SRb has allowed us to test
experimentally the role of its GTP binding site and its
TMD. Both lines of investigation yielded rather unex-
pected results. First, the GTP binding site of Srp102p ap-
pears to be surprisingly resilient to mutations that inacti-
vate other GTPases. When the GTP binding site is
sufficiently disturbed, however, SR function is lost. Inter-
estingly, in most cases tested the loss of activity parallels a
loss of the affinity of Srp102p for Srp101p. Second and
equally surprising, we find that the TMD of Srp102p is not
required for its function. Thus, the SR can function as a
soluble cytosolic factor that may only associate transiently
with ER membrane components most likely through an
interaction with other membrane proteins.
To our knowledge, the relative insensitivity of the GTP
binding site of Srp102p to mutational perturbation is un-
precedented by studies of other GTPases. Mutations were
chosen based on their predicted effects on blocking differ-
ent steps in the presumptive Srp102p GTPase cycle; yet
eight of the twelve mutations that change single or multi-
ple amino acids in single G-boxes in Srp102p have no dis-
cernible effect on the growth of cells or on SRP-dependent
protein translocation. We consider it likely that these mu-
tations have not caused enough of a change in steady-state
levels of the different nucleotide-bound forms of Srp102p
to exhibit a mutant phenotype. In each case tested, how-
Figure 8. Srp102p-DTMD and Srp101p form a
stable complex in the cytosol. A cytosolic extract
was prepared from strains containing Srp102p-
DTMD and Srp101p with or without an HA tag
(lanes 1–3, Srp101p-HA, WBY752; anes 4– 6, no
tag; WBY618 with pWB209). In A, 1 OD600
equivalent of cell cytosol was subjected to immu-
noprecipitation with anti-HA mAbs coupled di-
rectly to agarose beads. Coimmunoprecipitated
proteins were eluted from the beads, and were
then subjected to SDS-PAGE followed by West-
ern blot analysis using antisera against Srp102p.
Eluates from the immunoprecipitation are
shown in lanes 3 and 6 (E, eluate), while proteins
not bound during the immunoprecipitation are
shown in lanes 2 and 5 (S, supernatant). Lanes 1
and 4 (T, total) contain 1 OD600 cell equivalent of whole-cell extract as a marker for the amount of Srp102p-DTMD that is in each of the
immunoprecipitations. B shows the same type of experiment, but using the anti-Srp102p antibody coupled to beads to perform the im-
munoprecipitation followed by detection of Srp101p-HA with anti-HA mAbs. Note that lanes 4–6 are blank because the Srp101p
present in those lanes has no HA epitope.Ogg et al. b-Subunit of the Yeast SRP Receptor 353
ever, combination of mutations in single G boxes such that
now residues of two separate G-boxes are altered, resulted
in more severely impaired SR function. In all cases ana-
lyzed, the expression levels of Srp102p mutants were not
affected, thus making it unlikely that combination of mu-
tations caused global unfolding (which might be expected
to destabilize the protein in cells). We envision that each
G-box loop on the GTPase domain contributes binding
energy through contacts with the nucleotide. Upon disrup-
tion of the contributions of a single loop, nucleotide bind-
ing is still sufficiently tight to support Srp102p function,
whereas perturbation of multiple loops lowers the affinity
below a required threshold. It follows from this interpreta-
tion that none of the mutated side chains can be absolutely
required for Srp102p’s catalytic activity, i.e., each of the
mutant Srp102ps must still be capable of traversing SRb’s
GTPase cycle.
SRP-dependent protein targeting is evolutionarily
conserved. In bacteria, homologues of SRP54 and SRa
(termed Ffh and FtsY, respectively) have been found to
play an important role in membrane protein biogenesis
(Seluanov and Bibi, 1997; Ulbrandt et al., 1997). In con-
trast, no recognizable homologue for SRb is encoded in
the bacterial genome; SRb therefore may be an exclu-
sively eukaryotic invention. Our results show that the
yeast SR does not have to be an integral membrane pro-
tein to be functional; thus, the role of SRb is unlikely to be
solely that of a membrane anchor for SRa. Rather, our re-
sults suggest that an interaction between SRa and SRb is
required for targeting. As borne out by the mutational
analysis, this interaction in turn is dependent on features
in the GTPase domain of Srp102p, possibly reflecting reg-
ulation by its nucleotide-bound state. Thus, SRb could
function as an enabling switch that is required to recruit
SRa from an inactive pool into a heterodimeric complex
that then is active to promote protein targeting. Prokary-
otic FtsY may be constitutively active, not requiring such a
switch. In this role, SRb might increase the fidelity of pro-
tein targeting by sensing the status of downstream compo-
nents (e.g., the translocon) and activate SRa only when
unoccupied translocation sites are available. The interac-
tion of the activated SRa with the SRP/ribosome/nascent
chain complex may then carry out the nuts-and-bolts reac-
tion that releases the signal sequence from SRP and ascer-
tains proper docking of the ribosome onto the translocon.
Clearly, other models remain possible to account for the
presented results. To decipher the role of the GTPase do-
main of SRb, biochemical analyses will be required to ex-
tend the mutational studies initiated here and to define the
role of individual nucleotide-bound states of Srp102p. The
availability of active, soluble Srp101p–Srp102p-DTMD
complexes should greatly facilitate such analyses, as this
will allow functional studies without a requirement for te-
dious and often inefficient reconstitutions of detergent sol-
ubilized SRP receptor into artificial lipid bilayers.
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